Hormones, Endocrine Disorders, and Hemostasis

Massimo Franchini; Pier Paolo Vescovi; Franco Manzato; Emmanuel J Favaloro

doi:10.1055/s-0030-1270064

Seminars in Thrombosis and Hemostasis, Inhaltsverzeichnis

Semin Thromb Hemost 2011; 37(1): 003-006
DOI: 10.1055/s-0030-1270064

PREFACE

Hormones, Endocrine Disorders, and Hemostasis

Massimo Franchini¹ , Pier Paolo Vescovi² , Franco Manzato³ , Emmanuel J. Favaloro⁴

¹Servizio di Immuno-ematologia e Medicina Trasfusionale, Dipartimento di Patologia e Medicina di Laboratorio, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
²Divisione di Medicina, Ospedale “Carlo Poma,” Mantova; Italy
³Laboratorio di Analisi Chimico-Cliniche, Ospedale “Carlo Poma,” Mantova; Italy
⁴Department of Haematology, Institute of Clinical Pathology and Medical Research (ICPMR), Westmead Hospital, Westmead, Australia

Abstract

Volltext

Referenzen

REFERENCES

1 Franchini M, Lippi G, Manzato F, Vescovi P P, Targher G. Hemostatic abnormalities in endocrine and metabolic disorders. Eur J Endocrinol. 2010; 162 (3) 439-451
2 Targher G, Pichiri I, Zoppini G, Bonora E, Chonchol M. Hemostatic and fibrinolytic abnormalities in endocrine diseases: a narrative review. Semin Thromb Hemost. 2009; 35 (7) 605-612
3 Vescovi P P, Favaloro E J, Lippi G, Manzato F, Franchini M. The spectrum of coagulation abnormalities in thyroid disorders. Semin Thromb Hemost. 2011; 37 (1) 7-10
4 Squizzato A, Romualdi E, Büller H R, Gerdes V EA. Clinical review: thyroid dysfunction and effects on coagulation and fibrinolysis: a systematic review. J Clin Endocrinol Metab. 2007; 92 (7) 2415-2420
5 Franchini M. Hemostasis and thyroid diseases revisited. J Endocrinol Invest. 2004; 27 (9) 886-892
6 Franchini M, Montagnana M, Manzato F, Vescovi P P. Thyroid dysfunction and hemostasis: an issue still unresolved. Semin Thromb Hemost. 2009; 35 (3) 288-294
7 Mina A, Favaloro E J, Koutts J. Hemostatic dysfunction associated with endocrine disorders as a major risk factor and cause of human morbidity and mortality: a comprehensive meta-review. Semin Thromb Hemost. 2007; 33 (8) 798-809
8 Marongiu F, Barcellona D, Mameli A, Mariotti S. Thyroid disorders and hypocoagulability. Semin Thromb Hemost. 2011; 37 (1) 11-16
9 Marongiu F, Cauli C, Mameli G, Usai B, Mariotti S. Apathetic Graves' disease and acquired hemophilia due to factor VIIIc antibody. J Endocrinol Invest. 2002; 25 (3) 246-249
10 Erem C. Thyroid disorders and hypercoagulability. Semin Thromb Hemost. 2011; 37 (1) 17-26
11 Erem C, Kavgacı H, Ersöz HÖ et al. Blood coagulation and fibrinolytic activity in hypothyroidism. Int J Clin Pract. 2003; 57 (2) 78-81
12 Duntas L H, Biondi B. New insights into subclinical hypothyroidism and cardiovascular risk. Semin Thromb Hemost. 2011; 37 (1) 27-34
13 Duntas L H, Wartofsky L. Cardiovascular risk and subclinical hypothyroidism: focus on lipids and new emerging risk factors. What is the evidence?. Thyroid. 2007; 17 (11) 1075-1084
14 Duntas L H. Subclinical hypothyroidism: a misnomer in search of a new name. Thyroid. 2001; 11 (4) 361-362
15 Federici A B. Acquired von Willebrand syndrome associated with hypothyroidism: a mild bleeding disorder to be further investigated. Semin Thromb Hemost. 2011; 37 (1) 35-40
16 Federici A B, Rand J H, Bucciarelli P Subcommittee on von Willebrand Factor et al. Acquired von Willebrand syndrome: data from an international registry. Thromb Haemost. 2000; 84 (2) 345-349
17 Federici A B. Acquired von Willebrand syndrome: is it an extremely rare disorder or do we see only the tip of the iceberg?. J Thromb Haemost. 2008; 6 (4) 565-568
18 Squizzato A, Van Zaane B, Gerdes V EA, Büller H R. The influence of pituitary, adrenal, and parathyroid hormones on hemostasis and thrombosis. Semin Thromb Hemost. 2011; 37 (1) 41-48
19 Squizzato A, Gerdes V E, Ageno W, Büller H R. The coagulation system in endocrine disorders: a narrative review. Intern Emerg Med. 2007; 2 (2) 76-83
20 Mehdi A A, Salti I, Uthman I. Antiphospholipid syndrome: endocrinologic manifestations and organ involvement. Semin Thromb Hemost. 2011; 37 (1) 49-57
21 Asherson R A, Hughes G R. Hypoadrenalism, Addison's disease and antiphospholipid antibodies. J Rheumatol. 1991; 18 (1) 1-3
22 Targher G, Chonchol M, Zoppini G, Franchini M. Hemostatic disorders in type 1 diabetes mellitus. Semin Thromb Hemost. 2011; 37 (1) 58-65
23 Targher G, Bertolini L, Zoppini G, Zenari L, Falezza G. Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in type 1 diabetic patients without clinically manifest macroangiopathy. Diabet Med. 2005; 22 (8) 999-1004
24 Lippi G, Targher G, Favaloro E J, Franchini M. Venous thromboembolism in chronic liver disease. Semin Thromb Hemost. 2011; 37 (1) 66-76
25 Tripodi A, Mannucci P M. Abnormalities of hemostasis in chronic liver disease: reappraisal of their clinical significance and need for clinical and laboratory research. J Hepatol. 2007; 46 (4) 727-733
26 Tripodi A, Primignani M, Mannucci P M. Abnormalities of hemostasis and bleeding in chronic liver disease: the paradigm is challenged. Intern Emerg Med. 2010; 5 (1) 7-12
27 Lippi G, Franchini M. Pathogenesis of venous thromboembolism: when the cup runneth over. Semin Thromb Hemost. 2008; 34 (8) 747-761
28 Trigg D E, Wood M G, Kouides P A, Kadir R A. Hormonal influences on hemostasis in women. Semin Thromb Hemost. 2011; 37 (1) 77-86
29 Kadir R A, Economides D L, Sabin C A, Owens D, Lee C A. Variations in coagulation factors in women: effects of age, ethnicity, menstrual cycle and combined oral contraceptive. Thromb Haemost. 1999; 82 (5) 1456-1461
30 van Rooijen M, Silveira A, Thomassen S et al. APC resistance during the normal menstrual cycle. Thromb Haemost. 2007; 98 (6) 1246-1251
31 Franchini M. Haemostasis and pregnancy. Thromb Haemost. 2006; 95 (3) 401-413
32 Brodin E, Vikan T, Hansen J-B, Svartberg J. Testosterone, hemostasis, and cardiovascular diseases in men. Semin Thromb Hemost. 2011; 37 (1) 87-94
33 Laughlin G A, Barrett-Connor E, Bergstrom J. Low serum testosterone and mortality in older men. J Clin Endocrinol Metab. 2008; 93 (1) 68-75
34 Liu P Y, Death A K, Handelsman D J. Androgens and cardiovascular disease. Endocr Rev. 2003; 24 (3) 313-340